<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02492880</url>
  </required_header>
  <id_info>
    <org_study_id>91051317</org_study_id>
    <nct_id>NCT02492880</nct_id>
  </id_info>
  <brief_title>CoverEdge Algorithm Programming Study</brief_title>
  <official_title>Study to Characterize the Effects of Programming Features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator System Using the CoverEdge™ Surgical Leads</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, on-label, multi-center, non-randomized, exploratory, single-arm study
      to characterize the effects of programming features of the Boston Scientific Precision
      Spectra™ Spinal Cord Stimulator (SCS) System using the CoverEdge™ surgical lead.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Paresthesia distribution from subject completed paresthesia drawing questionnaire.</measure>
    <time_frame>minimum 25 days post IPG implant</time_frame>
  </primary_outcome>
  <enrollment type="Actual">15</enrollment>
  <condition>Chronic Pain</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Precision Spectra™ SCS system programming features</intervention_name>
    <description>Precision Spectra™ SCS system programming features using the CoverEdge surgical lead.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject implanted, on-label, with a commercially approved Boston Scientific Spectra
             neurostimulation system and at least one CoverEdge or CoverEdge X surgical lead, per
             local directions for use (DFU).

          -  Subject signed a valid, Institutional Review Board (IRB)-approved informed consent
             form.

          -  Subject is 18 years of age or older when written informed consent is obtained.

        Exclusion Criteria:

          -  Subject meets any contraindication in Boston Scientific (BSC) neurostimulation system
             local DFU.

          -  Subject is currently diagnosed with cognitive impairment, or exhibits any
             characteristic, that would limit study candidate's ability to assess pain relief or
             complete study assessments.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Boston Scientific Clinical Research Information Toll Free Number</name>
      <address>
        <city>Valencia</city>
        <state>California</state>
        <zip>91355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2015</study_first_submitted>
  <study_first_submitted_qc>July 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2015</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stimulation</keyword>
  <keyword>implantable</keyword>
  <keyword>pulse generator</keyword>
  <keyword>back pain</keyword>
  <keyword>chronic pain</keyword>
  <keyword>leg pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

